Creation of radiopaque thrombi for in vivo experiments

D. B. Brown, C. B. Glaiberman, A. W. Allen, Frank Lynch, Harjit Singh, P. L. Stagg, Peter Waybill

Research output: Contribution to journalArticle

Abstract

PURPOSE: A number of percutaneous thrombectomy devices are undergoing investigation for treatment of patients with venous thromboembolism. Use of radiopaque thrombus to monitor thrombus delivery and assess thrombectomy has been previously reported. The purpose of this project was to quantitatively test the effect of mixing different ratios of blood and contrast material to facilitate maximum thrombus formation and radiopacity. MATERIALS AND METHODS: The following ratio, s of blood and contrast material were mixed: 2 mL blood to 8 mL contrast material (ratio = 0.25), 4 mL blood to 6 mL contrast material (ratio = 0.67), 6 mL blood to 4 mL contrast material (ratio = 1.5), and 8 mL blood to 2 mL contrast material (ratio = 4). Contrast material was added at day 0, 3, or 6. Each sample received one of two ionic contrast agents to opacify the clots. At day 14, thrombus mass and opacity were determined. RESULTS: Three combinations of blood and contrast material produced maximum thrombus and radiopacity. These were sodium iothalamate 30% with a ratio of 4 with contrast material added on day 0 and sodium iothalamate 60% with a ratio of 1.5 with contrast material added on day 3 or 6. CONCLUSIONS: When forming radiopaque thrombi, significant differences can result from the ratio of blood to contrast material used. Contrast material type can also affect radiopacity and mass formed. The use of optimal ratios of blood to contrast material should maximize device evaluation with minimal wasting of valuable resources such as test subjects, physician time, and equipment.

Original languageEnglish (US)
Pages (from-to)1222-1226
Number of pages5
JournalJournal of Vascular and Interventional Radiology
Volume11
Issue number9
DOIs
StatePublished - Jan 1 2000

Fingerprint

Contrast Media
Thrombosis
Iothalamic Acid
Thrombectomy
Equipment and Supplies
Venous Thromboembolism
Physicians

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Brown, D. B. ; Glaiberman, C. B. ; Allen, A. W. ; Lynch, Frank ; Singh, Harjit ; Stagg, P. L. ; Waybill, Peter. / Creation of radiopaque thrombi for in vivo experiments. In: Journal of Vascular and Interventional Radiology. 2000 ; Vol. 11, No. 9. pp. 1222-1226.
@article{f22f1e64a231493db3b613e600759642,
title = "Creation of radiopaque thrombi for in vivo experiments",
abstract = "PURPOSE: A number of percutaneous thrombectomy devices are undergoing investigation for treatment of patients with venous thromboembolism. Use of radiopaque thrombus to monitor thrombus delivery and assess thrombectomy has been previously reported. The purpose of this project was to quantitatively test the effect of mixing different ratios of blood and contrast material to facilitate maximum thrombus formation and radiopacity. MATERIALS AND METHODS: The following ratio, s of blood and contrast material were mixed: 2 mL blood to 8 mL contrast material (ratio = 0.25), 4 mL blood to 6 mL contrast material (ratio = 0.67), 6 mL blood to 4 mL contrast material (ratio = 1.5), and 8 mL blood to 2 mL contrast material (ratio = 4). Contrast material was added at day 0, 3, or 6. Each sample received one of two ionic contrast agents to opacify the clots. At day 14, thrombus mass and opacity were determined. RESULTS: Three combinations of blood and contrast material produced maximum thrombus and radiopacity. These were sodium iothalamate 30{\%} with a ratio of 4 with contrast material added on day 0 and sodium iothalamate 60{\%} with a ratio of 1.5 with contrast material added on day 3 or 6. CONCLUSIONS: When forming radiopaque thrombi, significant differences can result from the ratio of blood to contrast material used. Contrast material type can also affect radiopacity and mass formed. The use of optimal ratios of blood to contrast material should maximize device evaluation with minimal wasting of valuable resources such as test subjects, physician time, and equipment.",
author = "Brown, {D. B.} and Glaiberman, {C. B.} and Allen, {A. W.} and Frank Lynch and Harjit Singh and Stagg, {P. L.} and Peter Waybill",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1051-0443(07)61368-2",
language = "English (US)",
volume = "11",
pages = "1222--1226",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "9",

}

Creation of radiopaque thrombi for in vivo experiments. / Brown, D. B.; Glaiberman, C. B.; Allen, A. W.; Lynch, Frank; Singh, Harjit; Stagg, P. L.; Waybill, Peter.

In: Journal of Vascular and Interventional Radiology, Vol. 11, No. 9, 01.01.2000, p. 1222-1226.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Creation of radiopaque thrombi for in vivo experiments

AU - Brown, D. B.

AU - Glaiberman, C. B.

AU - Allen, A. W.

AU - Lynch, Frank

AU - Singh, Harjit

AU - Stagg, P. L.

AU - Waybill, Peter

PY - 2000/1/1

Y1 - 2000/1/1

N2 - PURPOSE: A number of percutaneous thrombectomy devices are undergoing investigation for treatment of patients with venous thromboembolism. Use of radiopaque thrombus to monitor thrombus delivery and assess thrombectomy has been previously reported. The purpose of this project was to quantitatively test the effect of mixing different ratios of blood and contrast material to facilitate maximum thrombus formation and radiopacity. MATERIALS AND METHODS: The following ratio, s of blood and contrast material were mixed: 2 mL blood to 8 mL contrast material (ratio = 0.25), 4 mL blood to 6 mL contrast material (ratio = 0.67), 6 mL blood to 4 mL contrast material (ratio = 1.5), and 8 mL blood to 2 mL contrast material (ratio = 4). Contrast material was added at day 0, 3, or 6. Each sample received one of two ionic contrast agents to opacify the clots. At day 14, thrombus mass and opacity were determined. RESULTS: Three combinations of blood and contrast material produced maximum thrombus and radiopacity. These were sodium iothalamate 30% with a ratio of 4 with contrast material added on day 0 and sodium iothalamate 60% with a ratio of 1.5 with contrast material added on day 3 or 6. CONCLUSIONS: When forming radiopaque thrombi, significant differences can result from the ratio of blood to contrast material used. Contrast material type can also affect radiopacity and mass formed. The use of optimal ratios of blood to contrast material should maximize device evaluation with minimal wasting of valuable resources such as test subjects, physician time, and equipment.

AB - PURPOSE: A number of percutaneous thrombectomy devices are undergoing investigation for treatment of patients with venous thromboembolism. Use of radiopaque thrombus to monitor thrombus delivery and assess thrombectomy has been previously reported. The purpose of this project was to quantitatively test the effect of mixing different ratios of blood and contrast material to facilitate maximum thrombus formation and radiopacity. MATERIALS AND METHODS: The following ratio, s of blood and contrast material were mixed: 2 mL blood to 8 mL contrast material (ratio = 0.25), 4 mL blood to 6 mL contrast material (ratio = 0.67), 6 mL blood to 4 mL contrast material (ratio = 1.5), and 8 mL blood to 2 mL contrast material (ratio = 4). Contrast material was added at day 0, 3, or 6. Each sample received one of two ionic contrast agents to opacify the clots. At day 14, thrombus mass and opacity were determined. RESULTS: Three combinations of blood and contrast material produced maximum thrombus and radiopacity. These were sodium iothalamate 30% with a ratio of 4 with contrast material added on day 0 and sodium iothalamate 60% with a ratio of 1.5 with contrast material added on day 3 or 6. CONCLUSIONS: When forming radiopaque thrombi, significant differences can result from the ratio of blood to contrast material used. Contrast material type can also affect radiopacity and mass formed. The use of optimal ratios of blood to contrast material should maximize device evaluation with minimal wasting of valuable resources such as test subjects, physician time, and equipment.

UR - http://www.scopus.com/inward/record.url?scp=0033774731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033774731&partnerID=8YFLogxK

U2 - 10.1016/S1051-0443(07)61368-2

DO - 10.1016/S1051-0443(07)61368-2

M3 - Article

C2 - 11041483

AN - SCOPUS:0033774731

VL - 11

SP - 1222

EP - 1226

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 9

ER -